Specialty Pharmacy is central to health system ambulatory care and patient engagement. Loopback is here to help.

Loopback Rx modules are designed with and by specialty pharmacists to support patient opportunity assessment, decision-making and ease reporting requirements by assembling the relevant data to make decisions.

55%

growth in specialty medication fills per client

92%

median PDC for specialty therapies

400K

specialty pharmacy patients managed by clients on the platform

$3.1B

annual specialty medication revenue

Loopback Rx – Specialty Pharmacy Analytics

The Loopback Rx platform is comprised of interoperable modules (which can work independently or in combination) that provide actionable insights and tools to support health system pharmacies in their growth and patient care.

Identify patients that represent leakage and opportunity for your specialty pharmacy

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Filter dynamically by location, prescriber, drug and payer

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Develop and manage campaigns for growth opportunities and ROI analysis

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Quantify business case for additional resources and strategic initiatives
Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.
Address payer and manufacturer blocks
Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.
Understand revenue and margin opportunity by linking with pricing systems
Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Target high-risk or low-adherence patients

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Engage patients on high-complexity/ high-touch specialty medications

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Increase visibility across inpatient and outpatient care settings, across health system

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Leverage patient cohort and workflow tools
Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.
Disposition patient engagement to measure intervention effectiveness
Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.
Measure medication adherence metrics such as Proportion of Days Covered and Time to Therapy

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Asses clinical utilization metrics across all therapies

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Select filters to quickly identify at-risk patients

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Compare analytics to evaluate patient outcomes by pharmacy channel
Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.
Track therapy-specific clinical endpoints for high priority therapies
Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.
Calculate measures in support of URAC ® Reporting accreditation

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Automate REMS reporting

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Enable reporting of manufacturer data through Acentrus Link

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Provide custom reporting to external stakeholders such as manufacturers or payors

Praesent ut ligula non mi varius sagittis. Vestibulum eu odio ulla neque.

Therapy Specific Outcomes Coalition

The Therapy Specific Outcomes Coalition is comprised of 14 Integrated Delivery Networks, representing over 15M patient lives across hospital and community settings, including academic medical centers. Founding members select Therapy Areas of focus where specialty pharmacy plays a significant role in positive patient outcomes.

Therapy Areas

Multiple Sclerosis

Measures

  • Med adherence measures
  • Flare events
  • Relapse rate
  • Lymphocyte labs
  • Positive UTI labs
  • Anti-infection drug events
  • ED visits
  • Inpatient stays
  • Baseline Labs
  • Relative outcomes pre/post therapy adjustments

Population

  • 35K patients
  • 100+ encounters (avg)
  • 5-10 years history

Rheumatology

Measures

  • Med adherence measures
  • Flare events
  • Relapse rate
  • ESR Labs
  • CRP Labs
  • Steroid orders & usage
  • ED visits
  • Inpatient stays
  • # Joints impacted
  • Self-reported Pain
  • Global Scores
  • MDHAQ
  • HAQ Scores
  • CDAI Scores
  • PROMIS Scores
  • Baseline pre-therapy
  • Switching scores pre/post therapy adjustments

Population

  • 180K patients
  • 100+ encounters (avg)
  • 5-9 years history

Cystic Fibrosis

Measures

  • Med adherence measures
  • Exacerbation drug events
  • Exacerbation diagnoses
  • BMI levels and changes
  • FEV/FVC labs
  • ED visits
  • Inpatient admissions
  • Quarterly labs
  • Switching scores pre/post therapy adjustments

Chronic Lymphoblastic Leukemia

  • ED Visits
  • Inpatient admissions
  • Prevalence of adverse effects
  • Utilization of adjunctive therapies for side effect management
  • Prevalence of dose adjustments
  • Survival curves/Kaplan Meier
  • Presence of atrial fibrillation for patients on BTKi therapies

Coming soon!

Gastroenterology

Coming soon!

Coming soon!

Get Connected

  • *Indicates Required Field